Nestin depletion induces melanoma matrix metalloproteinases and invasion

Laboratory Investigation

Volumn 94, Issue 12, 2014, Pages 1382-1395

  Lee, Chung Wei ^a   Zhan, Qian ^a   Lezcano, Cecilia ^a   Frank, Markus H ^b   Huang, John ^a,c   Larson, Allison R ^a   Lin, Jennifer Y ^a   Wan, Marilyn T ^a   Lin, Ping I ^d   Ma, Jie ^b   Kleffel, Sonja ^a   Schatton, Tobias ^a   Lian, Christine G ^a   Murphy, George F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; INTERMEDIATE FILAMENT PROTEIN; MATRIX METALLOPROTEINASE; NESTIN; TRANSFORMING GROWTH FACTOR BETA; NES PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL AGGREGATION; CELL MIGRATION; CONNECTIVE TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL LINE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TUMOR INVASION; TUMOR XENOGRAFT; ANIMAL; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MATRIX METALLOPROTEINASES; MELANOMA; MICE; NEOPLASM INVASIVENESS; NESTIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84922481838     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.130     Document Type: Article

References (73)

1. Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 2011;278:16-27.
2. Guerry Dt, Synnestvedt M, Elder DE, et al. Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J Invest Dermatol 1993;100:342S-345S.
3. Hofmann UB, Eggert AA, Blass K, et al. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Cancer Res 2003;63:8221-8225.
4. Laga AC, Murphy GF. Cellular heterogeneity in vertical growth phase melanoma. Arch Pathol Lab Med 2010;134:1750-1757.
5. Yan C, Boyd DD. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 2007;211:19-26.
6. Maeda E, Sugimoto M, Ohashi T. Cytoskeletal tension modulates MMP- 1 gene expression from tenocytes on micropillar substrates. J Biomech 2013;46:991-997.
7. Akiyama M, Matsuda Y, Ishiwata T, et al. Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma. J Invest Dermatol 2013;133:1384-1387.
8. Wiese C, Rolletschek A, Kania G, et al. Nestin expression-a property of multi-lineage progenitor cells? Cell Mol Life Sci 2004;61:2510-2522.
9. Klein WM, Wu BP, Zhao S, et al. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007;20:102-107.
10. Schatton T, Murphy GF, Frank NY, et al. Identification of cells initiating human melanomas. Nature 2008;451:345-349.
11. Boiko AD, Razorenova OV, van de Rijn M, et al. Human melanomainitiating cells express neural crest nerve growth factor receptor CD271. Nature 2010;466:133-137.
12. Girouard SD, Murphy GF. Melanoma stem cells: not rare, but well done. Lab Invest 2011;91:647-664.
13. Laga AC, Zhan Q, Weishaupt C, et al. SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study. Exp Dermatol 2011;20:339-345.
14. Hyder CL, Lazaro G, Pylvanainen JW, et al. Nestin regulates prostate cancer cell invasion by influencing FAK and integrin localisation and functions. J Cell Sci 2014;127:2161-2173.
15. Girouard SD, Laga AC, Mihm MC, et al. SOX2 contributes to melanoma cell invasion. Lab Invest 2012;92:362-370.
16. Jouhilahti EM, Peltonen S, Callens T, et al. The development of cutaneous neurofibromas. Am J Pathol 2011;178:500-505.
17. Jarvinen TM, Kanninen P, Jeskanen L, et al. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus. Br J Dermatol 2007;157:970-980.
18. Sonoda Y, Matsumoto Y, Funakoshi M, et al. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J Biol Chem 2000;275: 16309-16315.
19. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981;11: 805-815.
20. Lu P, Li L, Kuno K, et al. Protective roles of the fractalkine/CX3CL1- CX3CR1 interactions in alkali-induced corneal neovascularization through enhanced antiangiogenic factor expression. J Immunol 2008;180:4283-4291.
21. Young L, Sung J, Stacey G, et al. Detection of Mycoplasma in cell cultures. Nat Protoc 2010;5:929-934.
22. Xu DS, Yang C, Proescholdt M, et al. Neuronatin in a subset of glioblastoma multiforme tumor progenitor cells is associated with increased cell proliferation and shorter patient survival. PLoS One 2012;7:e37811.
23. Thomay AA, Daley JM, Sabo E, et al. Disruption of interleukin-1 signaling improves the quality of wound healing. Am J Pathol 2009;174:2129-2136.
24. Corthorn J, Rey S, Chacon C, et al. Spatio-temporal expression of MMP- 2, MMP-9 and tissue kallikrein in uteroplacental units of the pregnant guinea-pig (Cavia porcellus). Reprod Biol Endocrinol 2007;5:27.
25. Doehn U, Hauge C, Frank SR, et al. RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol Cell 2009;35:511-522.
26. Hahn WC, Dessain SK, Brooks MW, et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002;22:2111-2123.
27. Larson AR, Lee CW, Lezcano C, et al. Melanoma spheroid formation involves laminin-associated vasculogenic mimicry. Am J Pathol 2014;184:71-78.
28. Pastrana E, Silva-Vargas V, Doetsch F. Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 2011;8:486-498.
29. Delcroix GJ, Curtis KM, Schiller PC, et al. EGF and bFGF pre-treatment enhances neural specification and the response to neuronal commitment of MIAMI cells. Differentiation 2010;80:213-227.
30. Huang YL, Shi GY, Jiang MJ, et al. Epidermal growth factor upregulates the expression of nestin through the Ras-Raf-ERK signaling axis in rat vascular smooth muscle cells. Biochem Biophys Res Commun 2008;377:361-366.
31. Fray MJ, Dickinson RP. Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1). Bioorg Med Chem Lett 2001;11:571-574.
32. Rasmussen HS, McCann PP. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther 1997;75:69-75.
33. Ma J, Lin JY, Alloo A, et al. Isolation of tumorigenic circulating melanoma cells. Biochem Biophys Res Commun 2010;402:711-717.
34. Lian CG, Xu Y, Ceol C, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012;150:1135-1146.
35. Laga AC, Lai CY, Zhan Q, et al. Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biology. Am J Pathol 2010;176:903-913.
36. Kaufmann WK, Nevis KR, Qu P, et al. Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression. J Invest Dermatol 2008;128:175-187.
37. Matsuda Y, Naito Z, Kawahara K, et al. Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis. Cancer Biol Ther 2011;11:512-523.
38. Kleeberger W, Bova GS, Nielsen ME, et al. Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis. Cancer Res 2007;67:9199-9206.
39. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010;141:52-67.
40. Schatton T, Frank MH. The in vitro spheroid melanoma cell culture assay: cues on tumor initiation? J Invest Dermatol 2010;130:1769-1771.
41. Kumar SM, Liu S, Lu H, et al. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 2012;31:4898-4911.
42. Chakraborti S, Mandal M, Das S, et al. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003;253:269-285.
43. Schlaepfer DD, Mitra SK. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 2004;14:92-101.
44. Cicchini C, Laudadio I, Citarella F, et al. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res 2008;314:143-152.
45. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-273.
46. Janji B, Melchior C, Gouon V, et al. Autocrine TGF-beta-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype. Int J Cancer 1999;83:255-262.
47. Su HT, Weng CC, Hsiao PJ, et al. Stem cell marker nestin is critical for TGF-beta1-mediated tumor progression in pancreatic cancer. Mol Cancer Res 2013;11:768-779.
48. Chang L, Goldman RD. Intermediate filaments mediate cytoskeletal crosstalk. Nat Rev Mol Cell Biol 2004;5:601-613.
49. Gilyarov AV. Nestin in central nervous system cells. Neurosci Behav Physiol 2008;38:165-169.
50. Liu W, Zhang Y, Hao J, et al. Nestin protects mouse podocytes against high glucose-induced apoptosis by a Cdk5-dependent mechanism. J Cell Biochem 2012;113:3186-3196.
51. Sahlgren CM, Pallari HM, He T, et al. A nestin scaffold links Cdk5/ p35 signaling to oxidant-induced cell death. EMBO J 2006;25: 4808-4819.
52. Yang J, Dominguez B, de Winter F, et al. Nestin negatively regulates postsynaptic differentiation of the neuromuscular synapse. Nat Neurosci 2011;14:324-330.
53. Piras F, Perra MT, Murtas D, et al. The stem cell marker nestin predicts poor prognosis in human melanoma. Oncol Rep 2010;23:17-24.
54. Piras F, Ionta MT, Lai S, et al. Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer. Eur J Histochem 2011;55:e39.
55. Clark Jr. WH, Ainsworth AM, Bernardino EA, et al. The developmental biology of primary human malignant melanomas. Semin Oncol 1975;2:83-103.
56. Cui Y, Yamada S. N-cadherin dependent collective cell invasion of prostate cancer cells is regulated by the N-terminus of alpha-catenin. PLoS One 2013;8:e55069.
57. Iida J, McCarthy JB. Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-beta. Melanoma Res 2007;17:205-213.
58. Hoek KS, Eichhoff OM, Schlegel NC, et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 2008;68:650-656.
59. Topczewska JM, Postovit LM, Margaryan NV, et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 2006;12:925-932.
60. Kuriyama S, Mayor R. Molecular analysis of neural crest migration. Philos Trans R Soc Lond B Biol Sci 2008;363:1349-1362.
61. Wang Y, McNiven MA. Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex. J Cell Biol 2012;196:375-385.
62. Kim M, Gans JD, Nogueira C, et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 2006;125:1269-1281.
63. Deramaudt TB, Dujardin D, Hamadi A, et al. FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion. Mol Biol Cell 2011;22:964-975.
64. Thannickal VJ, Lee DY, White ES, et al. Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem 2003;278: 12384-12389.
65. Wakefield LM, Smith DM, Masui T, et al. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 1987;105:965-975.
66. Tulley S, Chen WT. Transcriptional Regulation of Seprase in Invasive Melanoma Cells by Transforming Growth Factor-beta Signaling. J Biol Chem 2014;289:15280-15296.
67. Ishiwata T, Matsuda Y, Naito Z. Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. World J Gastroenterol 2011;17:409-418.
68. Loo DT, Althoen MC, Cotman CW. Down regulation of nestin by TGFbeta or serum in SFME cells accompanies differentiation into astrocytes. Neuroreport 1994;5:1585-1588.
69. Quan T, He T, Kang S, et al. Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo. J Invest Dermatol 2002;119:499-506.
70. Croft DR, Olson MF. Regulating the conversion between rounded and elongated modes of cancer cell movement. Cancer Cell 2008;14:349-351.
71. Lezcano C, Lee CW, Larson AR, et al. Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors. Mod Pathol 2014;27:1193-1202.
72. Han DW, Do JT, Arauzo-Bravo MJ, et al. Epigenetic hierarchy governing Nestin expression. Stem Cells 2009;27:1088-1097.
73. Estler M, Boskovic G, Denvir J, et al. Global analysis of gene expression changes during retinoic acid-induced growth arrest and differentiation of melanoma: comparison to differentially expressed genes in melanocytes vs melanoma. BMC Genomics 2008;9:478.